Urology
Volume 72, Issue 1 , Pages 32-33 , July 2008

Editorial Comment

References 

  1. Welch BJ, Graybeal D, Moe OW, et al. Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis. 2006;48(4):555–563
  2. Shorvon SD. Safety of topiramate: adverse events and relationships to dosing. Epilepsia. 1996;37(suppl 2):S18–S22

PII: S0090-4295(08)00127-1

doi: 10.1016/j.urology.2008.01.047

Urology
Volume 72, Issue 1 , Pages 32-33 , July 2008

Article Tools